GENEREX BIOTECHNOLOGY CORP
GNBT
GNBT was delisted on the 20th of October, 2010.
3 hedge funds and large institutions have $1.56K invested in GENEREX BIOTECHNOLOGY CORP in 2013 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
50% more funds holding
Funds holding: 2 → 3 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$1.56K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Janney Montgomery Scott
Philadelphia,
Pennsylvania
| $1.56K | +$1.56K | +54,400 | New |
|
GNBT Hedge Fund Activity: Q4 2013 in Review
3 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in GENEREX BIOTECHNOLOGY CORP (GNBT) for Q4 2013, worth a combined $1.56K.
Buyers outnumbered sellers: 2 funds opened new GNBT positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Janney Montgomery Scott, opening a new position worth an estimated $1.56K.
- 3 institutional investors held GENEREX BIOTECHNOLOGY CORP (GNBT) as of Q4 2013, up from 2 in Q3 2013.
- Funds reported $1.56K of GENEREX BIOTECHNOLOGY CORP stock for Q4 2013.
- 2 funds opened new GENEREX BIOTECHNOLOGY CORP positions in Q4 2013 and 1 closed out, a net change of +1 holder.
- The largest GENEREX BIOTECHNOLOGY CORP buyer in Q4 2013 was Janney Montgomery Scott, an estimated $1.56K added.
Based on aggregated 13F filings for Q4 2013.